Cargando...
Initial Physician Experience with [(18)F]Flutemetamol Amyloid PET Imaging Following Availability for Routine Clinical Use in Japan
BACKGROUND: Brain amyloid is a neuropathological hallmark of Alzheimer’s disease (AD). By visualizing brain amyloid, positron emission tomography (PET) may influence the diagnostic assessment and management of patients with cognitive impairment. OBJECTIVE: As part of a Japanese post-approval study t...
Gardado en:
| Publicado en: | J Alzheimers Dis Rep |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
IOS Press
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7369136/ https://ncbi.nlm.nih.gov/pubmed/32715277 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/ADR-190150 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|